Nupur Verma to Lung Neoplasms
This is a "connection" page, showing publications Nupur Verma has written about Lung Neoplasms.
Connection Strength
1.304
-
Verma N, Wu M, Altmayer S. Lung Cancer Screening: How We do It and Why. Semin Roentgenol. 2020 Jan; 55(1):14-22.
Score: 0.402
-
Asumu H, Estrin Y, Mohammed TL, Verma N. Benign Metastasizing Leiomyoma. Curr Probl Diagn Radiol. 2017 May - Jun; 46(3):257-259.
Score: 0.321
-
Barreto I, Verma N, Quails N, Olguin C, Correa N, Mohammed TL. Patient size matters: Effect of tube current modulation on size-specific dose estimates (SSDE) and image quality in low-dose lung cancer screening CT. J Appl Clin Med Phys. 2020 Apr; 21(4):87-94.
Score: 0.104
-
Machado Medeiros T, Altmayer S, Watte G, Zanon M, Basso Dias A, Henz Concatto N, Hoefel Paes J, Mattiello R, de Souza Santos F, Mohammed TL, Verma N, Hochhegger B. 18F-FDG PET/CT and whole-body MRI diagnostic performance in M staging for non-small cell lung cancer: a systematic review and meta-analysis. Eur Radiol. 2020 Jul; 30(7):3641-3649.
Score: 0.103
-
Altmayer S, Verma N, Francisco MZ, Almeida RF, Mohammed TL, Hochhegger B. Classification and Imaging Findings of Lung Neoplasms. Semin Roentgenol. 2020 Jan; 55(1):41-50.
Score: 0.100
-
Basso Dias A, Zanon M, Altmayer S, Sartori Pacini G, Henz Concatto N, Watte G, Garcez A, Mohammed TL, Verma N, Medeiros T, Marchiori E, Irion K, Hochhegger B. Fluorine 18-FDG PET/CT and Diffusion-weighted MRI for Malignant versus Benign Pulmonary Lesions: A Meta-Analysis. Radiology. 2019 02; 290(2):525-534.
Score: 0.094
-
Riley L, Verma N, Mohammed TL, Ataya A. Pulmonary Lymphangitic Carcinomatosis From Renal Cell Carcinoma. Curr Probl Diagn Radiol. 2021 Jan - Feb; 50(1):104-107.
Score: 0.092
-
Ahmed A, Verma N, Barreto I, Mohammed TL. Low-dose Lung Cancer Screening at an Academic Medical Center: Initial Experience and Dose Reduction Strategies. Acad Radiol. 2018 08; 25(8):1025-1030.
Score: 0.089